{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:11:32Z","timestamp":1774005092853,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023618","name":"Office of The Provost","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jss.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:42:18Z","timestamp":1770244938000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preoperative Glucagon-like Peptide-1 Therapy in Bariatric Surgery Patients With Morbid Obesity (PreMO): Rationale and Study Design for a Randomized Controlled Trial"],"prefix":"10.1016","volume":"319","author":[{"given":"Varun","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen A.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy I.","family":"Kimbrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Rockich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara S.","family":"Nikolajczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"William B.","family":"Inabnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-348X","authenticated-orcid":false,"given":"Marlene E.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.01.004_bib1","series-title":"Obesity and overweight","year":"2024"},{"key":"10.1016\/j.jss.2026.01.004_bib2","series-title":"Center for disease control","year":"2024"},{"key":"10.1016\/j.jss.2026.01.004_bib3","series-title":"Most Obese States","year":"2025"},{"key":"10.1016\/j.jss.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/10934529.2014.882645","article-title":"The evaluation of heavy metal content in water and sediments of small reservoirs in light of various environmental quality regulations","volume":"49","author":"Michalec","year":"2014","journal-title":"J Environ Sci Health A Tox Hazard Subst Environ Eng"},{"key":"10.1016\/j.jss.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2026.01.004_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109900","article-title":"Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg\/m(2): a 5-year randomized controlled trial","volume":"188","author":"Cheng","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jss.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","article-title":"Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study","volume":"37","author":"Ilanga","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jss.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s11695-013-0990-3","article-title":"Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial","volume":"23","author":"O'Brien","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1038\/s41598-024-57724-5","article-title":"Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis","volume":"14","author":"Pipek","year":"2024","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jss.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/SLA.0000000000005003","article-title":"Patient-reported outcomes after metabolic surgery versus medical therapy for diabetes: insights from the STAMPEDE randomized trial","volume":"274","author":"Aminian","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamcollsurg.2017.12.032","article-title":"Short-term preoperative weight loss and postoperative outcomes in bariatric surgery","volume":"226","author":"Hutcheon","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.soard.2007.05.002","article-title":"Weight loss before gastric bypass: feasibility and effect on postoperative weight loss and weight loss maintenance","volume":"3","author":"Ali","year":"2007","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jss.2026.01.004_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4803","article-title":"Association of preoperative body weight and weight loss with risk of death after bariatric surgery","volume":"3","author":"Sun","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jss.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/XCS.0000000000001036","article-title":"Impact of preoperative weight loss on 30-Day complication rate after bariatric surgery","volume":"238","author":"Saleh","year":"2024","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/jmas.JMAS_297_20","article-title":"Effect of pre-operative weight loss on patients' outcomes undergoing laparoscopic sleeve gastrectomy","volume":"18","author":"Sen","year":"2022","journal-title":"J Minim Access Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/dom.16247","article-title":"Novel pharmacotherapies for weight loss: understanding the role of incretins to enable weight loss and improved health outcomes","volume":"27","author":"Forst","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jss.2026.01.004_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jss.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2026.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae284","article-title":"Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review","volume":"111","author":"Cohen","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00423-025-03831-4","article-title":"GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis","volume":"410","author":"Tan","year":"2025","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jss.2026.01.004_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jss.2026.01.004_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-\/-) and LDLr(-\/-) mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jss.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jss.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1111\/dom.16366","article-title":"The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: a systematic review and meta-analysis","volume":"27","author":"Ren","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11695-019-03926-0","article-title":"Effect of bariatric surgery on serum inflammatory factors of Obese patients: a systematic review and meta-analysis","volume":"29","author":"Askarpour","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s11695-012-0643-y","article-title":"Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery","volume":"22","author":"Ill\u00e1n-G\u00f3mez","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s11695-020-04411-9","article-title":"Impact of weight loss on inflammation state and endothelial markers among individuals with extreme obesity after gastric bypass surgery: a 2-Year Follow-up study","volume":"30","author":"Farias","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11695-022-06444-8","article-title":"Change in adipokines and gastrointestinal hormones after bariatric surgery: a meta-analysis","volume":"33","author":"Huang","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.jss.2026.01.004_bib43","article-title":"The roles and associated mechanisms of adipokines in development of metabolic syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jss.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a key regulator of the adipose organ","volume":"23","author":"Pic\u00f3","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jss.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.jss.2026.01.004_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/17446651.1.2.255","article-title":"Obesity and the renin- angiotensin-aldosterone system","volume":"1","author":"Sharma","year":"2006","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jss.2026.01.004_bib47","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.tips.2011.07.006","article-title":"The renin-angiotensin-aldosterone system and glucose homeostasis","volume":"32","author":"Luther","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jss.2026.01.004_bib48","article-title":"The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jss.2026.01.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113499","article-title":"Tirzepatide's role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance","volume":"143","author":"Xia","year":"2024","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:03:38Z","timestamp":1773997418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S0022480426000090"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.01.004","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Glucagon-like Peptide-1 Therapy in Bariatric Surgery Patients With Morbid Obesity (PreMO): Rationale and Study Design for a Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}